Articoli con mandati relativi all'accesso pubblico - Giuseppe ToniniUlteriori informazioni
Non disponibile pubblicamente: 1
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence
E Krasniqi, L Pizzuti, G Barchiesi, D Sergi, S Carpano, C Botti, R Kayal, ...
Journal of Cellular Physiology 235 (11), 7900-7910, 2020
Mandati: Fondazione AIRC per la Ricerca sul Cancro
Disponibili pubblicamente: 30
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...
The lancet oncology 18 (12), 1688-1700, 2017
Mandati: UK Medical Research Council, National Institute for Health Research, UK
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a …
RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ...
The Lancet 401 (10391), 1853-1865, 2023
Mandati: Health Research Board, Ireland
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis
FR Bertani, P Mozetic, M Fioramonti, M Iuliani, G Ribelli, F Pantano, ...
Scientific reports 7 (1), 8965, 2017
Mandati: Governo Italiano
Denosumab for treatment of hypercalcemia of malignancy
MI Hu, IG Glezerman, S Leboulleux, K Insogna, R Gucalp, W Misiorowski, ...
The Journal of Clinical Endocrinology & Metabolism 99 (9), 3144-3152, 2014
Mandati: US National Institutes of Health
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective …
DJ Pinato, J Tabernero, M Bower, L Scotti, M Patel, E Colomba, S Dolly, ...
The Lancet Oncology 22 (12), 1669-1680, 2021
Mandati: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
S De Placido, C Gallo, M De Laurentiis, G Bisagni, G Arpino, MG Sarobba, ...
The Lancet Oncology 19 (4), 474-485, 2018
Mandati: Governo Italiano
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
F Pantano, M Croset, K Driouch, N Bednarz-Knoll, M Iuliani, G Ribelli, ...
Oncogene 40 (7), 1284-1299, 2021
Mandati: German Research Foundation, National Institute of Health and Medical …
Propolis in the prevention of oral mucositis in breast cancer patients receiving adjuvant chemotherapy: A pilot randomised controlled trial
M Piredda, G Facchinetti, V Biagioli, D Giannarelli, G Armento, G Tonini, ...
European journal of cancer care 26 (6), e12757, 2017
Mandati: US National Institutes of Health
Outcomes of the SARS-CoV-2 omicron (B. 1.1. 529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre …
DJ Pinato, D Ferrante, G Hanbury, M Bower, R Salazar, O Mirallas, ...
The Lancet Oncology 23 (7), 865-875, 2022
Mandati: US National Institutes of Health, Cancer Research UK, National Institute for …
Factors influencing the clinical presentation of breakthrough pain in cancer patients
S Mercadante, P Marchetti, A Cuomo, A Caraceni, RD Mediati, R Vellucci, ...
Cancers 10 (6), 175, 2018
Mandati: Forskningsrådet för arbetsliv, hälsa och välfärd
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
G Bon, L Pizzuti, V Laquintana, R Loria, M Porru, C Marchiò, E Krasniqi, ...
Journal of Experimental & Clinical Cancer Research 39, 1-14, 2020
Mandati: Governo Italiano, Fondazione AIRC per la Ricerca sul Cancro
Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint blockade in patients with cancer
A Cortellini, A D'Alessio, S Cleary, S Buti, M Bersanelli, P Bordi, G Tonini, ...
Clinical Cancer Research 29 (14), 2714-2724, 2023
Mandati: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
The synergistic effect of everolimus and chloroquine on endothelial cell number reduction is paralleled by increased apoptosis and reduced autophagy occurrence
A Grimaldi, ML Balestrieri, N D'Onofrio, G Di Domenico, C Nocera, ...
PLoS One 8 (11), e79658, 2013
Mandati: Governo Italiano
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer
DJ Pinato, D Ferrante, J Aguilar-Company, M Bower, R Salazar, ...
European Journal of Cancer 171, 64-74, 2022
Mandati: National Institute for Health Research, UK, Wellcome Trust, Fondazione AIRC …
Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer
T Pascual, G Perrone, S Morales, J de la Haba, M González-Rivera, ...
Oncotarget 8 (13), 21930, 2017
Mandati: Government of Spain, Susan G. Komen
SARS-CoV-2 omicron (B. 1.1. 529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
A Cortellini, J Tabernero, U Mukherjee, R Salazar, A Sureda, C Maluquer, ...
The Lancet Oncology 24 (4), 335-346, 2023
Mandati: Cancer Research UK, National Institute for Health Research, UK, Wellcome …
A pathology-based combined model to identify PAM50 non-luminal intrinsic disease in hormone receptor-positive HER2-negative breast cancer
T Pascual, M Martin, A Fernández-Martínez, L Paré, E Alba, ...
Frontiers in oncology 9, 303, 2019
Mandati: Government of Spain
Malignant transformation of well‐differentiated papillary mesothelioma 13 years after the diagnosis: a case report
L Costanzo, S Scarlata, G Perrone, L Rossi, A Papa, FM Di Matteo, ...
The clinical respiratory journal 8 (1), 124-129, 2014
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Wellcome …
Large-scale profiling of extracellular vesicles identified miR-625-5p as a novel biomarker of immunotherapy response in advanced non-small-cell lung cancer patients
F Pantano, F Zalfa, M Iuliani, S Simonetti, P Manca, A Napolitano, S Tiberi, ...
Cancers 14 (10), 2435, 2022
Mandati: Governo Italiano
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software